Recruiting

Observational Study

Sponsor:

Hamilton Health Sciences Corporation

Code:

NCT00182117

Conditions

Bleeding

End Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study is examining the risk and protective factors associated with bleeding in the hemodialysis population.

Conditions

Bleeding

End Stage Renal Disease

Study ID

NCT00182117

Start date

Oct, 2003

Status verified date

Sep, 2005

Completion date

Apr, 2006

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patient is undergoing hemodialysis

Exclusion Criteria:

  • This is an observational study. No exclusion criteria required.

Study Design

Enrollment

490 participants

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Christian G Rabbat, MD

905-522-1155rabbatc@mcmaster.ca

Catherine M Clase, MD

905-522-1155clase@mcmaster.ca

Locations

St. Joseph's Healthcare

Recruiting

Hamilton, Ontario, Canada, L8N 4A6

Contacts

Christian G Rabbat, MD

905-522-1155rabbatc@mcmaster.ca

Catherine M Clase, MD

905-522-1155clase@mcmaster.ca

More Information

Sponsor

Hamilton Health Sciences Corporation

Last update posted

Jan 24, 2006

Last verified

Sep, 2005

Keywords

  • bleeding
  • end stage renal disease
  • antiplatelet therapy
  • anticoagulant therapy
  • hemodialysis

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Hamilton Health Sciences Corporation on 2006-01-24.